BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 34362785)

  • 1. Metabolite Biomarkers of CKD Progression in Children.
    Denburg MR; Xu Y; Abraham AG; Coresh J; Chen J; Grams ME; Feldman HI; Kimmel PL; Rebholz CM; Rhee EP; Vasan RS; Warady BA; Furth SL;
    Clin J Am Soc Nephrol; 2021 Aug; 16(8):1178-1189. PubMed ID: 34362785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low Serum Bicarbonate and CKD Progression in Children.
    Brown DD; Roem J; Ng DK; Reidy KJ; Kumar J; Abramowitz MK; Mak RH; Furth SL; Schwartz GJ; Warady BA; Kaskel FJ; Melamed ML
    Clin J Am Soc Nephrol; 2020 Jun; 15(6):755-765. PubMed ID: 32467307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibroblast Growth Factor 23 and Risk of CKD Progression in Children.
    Portale AA; Wolf MS; Messinger S; Perwad F; Jüppner H; Warady BA; Furth SL; Salusky IB
    Clin J Am Soc Nephrol; 2016 Nov; 11(11):1989-1998. PubMed ID: 27561289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of Rapid Progression of Glomerular and Nonglomerular Kidney Disease in Children and Adolescents: The Chronic Kidney Disease in Children (CKiD) Cohort.
    Warady BA; Abraham AG; Schwartz GJ; Wong CS; Muñoz A; Betoko A; Mitsnefes M; Kaskel F; Greenbaum LA; Mak RH; Flynn J; Moxey-Mims MM; Furth S
    Am J Kidney Dis; 2015 Jun; 65(6):878-88. PubMed ID: 25799137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progression of pediatric CKD of nonglomerular origin in the CKiD cohort.
    Fathallah-Shaykh SA; Flynn JT; Pierce CB; Abraham AG; Blydt-Hansen TD; Massengill SF; Moxey-Mims MM; Warady BA; Furth SL; Wong CS
    Clin J Am Soc Nephrol; 2015 Apr; 10(4):571-7. PubMed ID: 25635034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma Biomarkers of Tubular Injury and Inflammation Are Associated with CKD Progression in Children.
    Greenberg JH; Abraham AG; Xu Y; Schelling JR; Feldman HI; Sabbisetti VS; Gonzalez MC; Coca S; Schrauben SJ; Waikar SS; Ramachandran VS; Shlipak MG; Warady B; Kimmel PL; Bonventre JV; Denburg M; Parikh CR; Furth S;
    J Am Soc Nephrol; 2020 May; 31(5):1067-1077. PubMed ID: 32234829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Serum Soluble Urokinase Receptor Levels With Progression of Kidney Disease in Children.
    Schaefer F; Trachtman H; Wühl E; Kirchner M; Hayek SS; Anarat A; Duzova A; Mir S; Paripovic D; Yilmaz A; Lugani F; Arbeiter K; Litwin M; Oh J; Matteucci MC; Gellermann J; Wygoda S; Jankauskiene A; Klaus G; Dusek J; Testa S; Zurowska A; Caldas Afonso A; Tracy M; Wei C; Sever S; Smoyer W; Reiser J;
    JAMA Pediatr; 2017 Nov; 171(11):e172914. PubMed ID: 28873129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum metabolomic profiling and incident CKD among African Americans.
    Yu B; Zheng Y; Nettleton JA; Alexander D; Coresh J; Boerwinkle E
    Clin J Am Soc Nephrol; 2014 Aug; 9(8):1410-7. PubMed ID: 25011442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Time-Varying Blood Pressure With Chronic Kidney Disease Progression in Children.
    Reynolds BC; Roem JL; Ng DKS; Matsuda-Abedini M; Flynn JT; Furth SL; Warady BA; Parekh RS
    JAMA Netw Open; 2020 Feb; 3(2):e1921213. PubMed ID: 32058554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of the Urine-to-Plasma Urea Ratio With CKD Progression.
    Liu J; Bankir L; Verma A; Waikar SS; Palsson R
    Am J Kidney Dis; 2023 Apr; 81(4):394-405. PubMed ID: 36356680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating Kidney Function Decline in Children with Chronic Kidney Disease Using a Multi-Institutional Electronic Health Record Database.
    Gluck CA; Forrest CB; Davies AG; Maltenfort M; Mcdonald JR; Mitsnefes M; Dharnidharka VR; Dixon BP; Flynn JT; Somers MJ; Smoyer WE; Neu A; Hovinga CA; Skversky AL; Eissing T; Kaiser A; Breitenstein S; Furth SL; Denburg MR
    Clin J Am Soc Nephrol; 2023 Feb; 18(2):173-182. PubMed ID: 36754006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum Metabolomic Alterations Associated with Proteinuria in CKD.
    Luo S; Coresh J; Tin A; Rebholz CM; Appel LJ; Chen J; Vasan RS; Anderson AH; Feldman HI; Kimmel PL; Waikar SS; Köttgen A; Evans AM; Levey AS; Inker LA; Sarnak MJ; Grams ME;
    Clin J Am Soc Nephrol; 2019 Mar; 14(3):342-353. PubMed ID: 30733224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolomic Markers of Kidney Function Decline in Patients With Diabetes: Evidence From the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Kwan B; Fuhrer T; Zhang J; Darshi M; Van Espen B; Montemayor D; de Boer IH; Dobre M; Hsu CY; Kelly TN; Raj DS; Rao PS; Saraf SL; Scialla J; Waikar SS; Sharma K; Natarajan L;
    Am J Kidney Dis; 2020 Oct; 76(4):511-520. PubMed ID: 32387023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Nonoxidized Parathyroid Hormone with Cardiovascular and Kidney Disease Outcomes in Chronic Kidney Disease.
    Seiler-Mussler S; Limbach AS; Emrich IE; Pickering JW; Roth HJ; Fliser D; Heine GH
    Clin J Am Soc Nephrol; 2018 Apr; 13(4):569-576. PubMed ID: 29507005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex and Glomerular Filtration Rate Trajectories in Children.
    Bonnéric S; Karadkhele G; Couchoud C; Patzer RE; Greenbaum LA; Hogan J
    Clin J Am Soc Nephrol; 2020 Mar; 15(3):320-329. PubMed ID: 32111703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammation and Progression of CKD: The CRIC Study.
    Amdur RL; Feldman HI; Gupta J; Yang W; Kanetsky P; Shlipak M; Rahman M; Lash JP; Townsend RR; Ojo A; Roy-Chaudhury A; Go AS; Joffe M; He J; Balakrishnan VS; Kimmel PL; Kusek JW; Raj DS;
    Clin J Am Soc Nephrol; 2016 Sep; 11(9):1546-1556. PubMed ID: 27340285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NT-proBNP and troponin T and risk of rapid kidney function decline and incident CKD in elderly adults.
    Bansal N; Katz R; Dalrymple L; de Boer I; DeFilippi C; Kestenbaum B; Park M; Sarnak M; Seliger S; Shlipak M
    Clin J Am Soc Nephrol; 2015 Feb; 10(2):205-14. PubMed ID: 25605700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low levels of urinary epidermal growth factor predict chronic kidney disease progression in children.
    Azukaitis K; Ju W; Kirchner M; Nair V; Smith M; Fang Z; Thurn-Valsassina D; Bayazit A; Niemirska A; Canpolat N; Bulut IK; Yalcinkaya F; Paripovic D; Harambat J; Cakar N; Alpay H; Lugani F; Mencarelli F; Civilibal M; Erdogan H; Gellermann J; Vidal E; Tabel Y; Gimpel C; Ertan P; Yavascan O; Melk A; Querfeld U; Wühl E; Kretzler M; Schaefer F; ;
    Kidney Int; 2019 Jul; 96(1):214-221. PubMed ID: 31005273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Risk Factors for Progression of Diabetic and Nondiabetic CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Anderson AH; Xie D; Wang X; Baudier RL; Orlandi P; Appel LJ; Dember LM; He J; Kusek JW; Lash JP; Navaneethan SD; Ojo A; Rahman M; Roy J; Scialla JJ; Sondheimer JH; Steigerwalt SP; Wilson FP; Wolf M; Feldman HI;
    Am J Kidney Dis; 2021 Jan; 77(1):56-73.e1. PubMed ID: 32866540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma Soluble Urokinase Plasminogen Activator Receptor (suPAR) and CKD Progression in Children.
    Weidemann DK; Abraham AG; Roem JL; Furth SL; Warady BA
    Am J Kidney Dis; 2020 Aug; 76(2):194-202. PubMed ID: 31987488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.